Literature DB >> 24720853

Infant wheeze, comorbidities and school age asthma.

Asa Neuman1, Anna Bergström, Per Gustafsson, Per Thunqvist, Niklas Andersson, Lennart Nordvall, Inger Kull, Magnus Wickman.   

Abstract

BACKGROUND: Factors associated with early onset of wheeze have been described, but there is limited knowledge on which of these infant wheezers who will have developed asthma in school age. The aim was to identify clinical risk factors for asthma in the 8-yr-old children that wheezed during infancy in a population-based setting.
METHODS: Three thousand two hundred and fifty-one children from a population-based birth cohort followed prospectively from infancy until age 8 yr were included in the study. Data were analyzed using multivariate logistic regression analysis.
RESULTS: Parents reported any wheeze episode before age 2 yr in 823 subjects (25%). Infant wheezers had an almost fourfold risk of asthma at age 8 [adjusted odds ratio (aOR) 3.68, 95% CI 2.74-4.96], equivalent to an asthma prevalence of 14% compared with 4% among non-wheezers (p < 0.001). After adjustments for sex, exposure to tobacco smoke and indoor dampness/mould, allergic heredity (aOR 1.53, 95% CI 1.02-2.30), increased frequency of wheeze (aOR 3.41, 95% CI 2.09-5.56 for children with ≥3 episodes compared with ≤2 episodes during the first 2 yr of life), infant eczema (aOR 2.31, 95% CI 1.52-3.49), and recurrent abdominal pain (aOR 2.33, 95% CI 1.30-4.16) remained risk factors for school age asthma in the infant wheezing group.
CONCLUSIONS: Among infant wheezers, allergic heredity, increased severity of wheeze, infant eczema, and recurrent abdominal pain were independent risk factors for asthma at age 8 yr. Among children with three or four of these risk factors, 38% had asthma at school age.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Barn/Children, Allergy and Milieu in Stockholm, an Epidemiologic study; birth cohort; child; gastroesophageal reflux disease; prediction

Mesh:

Year:  2014        PMID: 24720853     DOI: 10.1111/pai.12223

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  5 in total

1.  Characterization of longitudinal wheeze phenotypes from infancy to adolescence in Project Viva, a prebirth cohort study.

Authors:  Joanne E Sordillo; Brent A Coull; Sheryl L Rifas-Shiman; Ann Chen Wu; Sharon M Lutz; Marie-France Hivert; Emily Oken; Diane R Gold
Journal:  J Allergy Clin Immunol       Date:  2019-11-06       Impact factor: 10.793

2.  Factors predicting persistence of early wheezing through childhood and adolescence: a systematic review of the literature.

Authors:  Carlos E Rodríguez-Martínez; Monica P Sossa-Briceño; Jose A Castro-Rodriguez
Journal:  J Asthma Allergy       Date:  2017-03-27

3.  Clinical phenotype and allergen sensitization in the first 2 years as predictors of atopic disorders at age 5 years.

Authors:  Phaik Ling Quah; Evelyn Xiu Ling Loo; Gabriella Nadine Li Yuan Lee; I-Chun Kuo; Irvin Gerez; Genevieve Villablanca Llanora; Yiong Huak Chan; Marion Aw; Lynette Pei-Chi Shek; Bee Wah Lee
Journal:  World Allergy Organ J       Date:  2015-12-02       Impact factor: 4.084

4.  The effect of recombinant human interferon α1b treatment of infants hospitalized with lower respiratory tract infection on subsequent wheezing.

Authors:  Lihua Yang; Guocheng Zhang; Lusheng Huang; Xiaoling Ren; Yanqi Su; Chengxiu Wang; Yuanbin Shi; Liao Li; Hui Shan; Jing Chen; Jianxin Xiong; Xue Xue; Shaofeng Song; Li Zhao; Shuhua An; Haiming Yu; Hong Cao; Lin Zhao; Ming Li; Xiaocui Sheng; Yajun Wang
Journal:  J Pediatr (Rio J)       Date:  2021-02-13       Impact factor: 2.990

5.  Operational definitions of paediatric asthma used in epidemiological studies: A systematic review.

Authors:  Mohammad Shahidul Islam; Samin Huq; Salahuddin Ahmed; Sudipto Roy; Jürgen Schwarze; Aziz Sheikh; Samir K Saha; Steve Cunningham; Harish Nair
Journal:  J Glob Health       Date:  2021-07-17       Impact factor: 4.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.